Ala-Eddine Deghmane1, Eva Hong1, Muhamed-Kheir Taha2. 1. Institut Pasteur, Invasive Bacterial Infection and National Reference Centre for Meningococci, Paris, France. 2. Institut Pasteur, Invasive Bacterial Infection and National Reference Centre for Meningococci, Paris, France mktaha@pasteur.fr.
Abstract
OBJECTIVES: Reduced susceptibility to penicillin G in Neisseria meningitidis is mainly due to alterations in PBP2 encoded by the penA gene. However, this phenotype was not associated with reduced susceptibility to third-generation cephalosporins (C3Gs). We aimed to study the emergence of meningococci with reduced susceptibility to C3Gs (MIC >0.06 mg/L) in France since 2012. METHODS: Invasive meningococcal isolates were typed by MLST and penA sequencing and their antibiotic susceptibility was tested. RESULTS: Isolates with reduced susceptibility to C3Gs represented 2% of all invasive isolates from 2012-15, but were absent before. They harboured a new penA allele, penA327, that was also detected in isolates from urethritis cases and in gonococci. CONCLUSIONS: Surveillance of these isolates should be enhanced as they may jeopardize the use of C3Gs in the management of invasive meningococcal disease.
OBJECTIVES: Reduced susceptibility to penicillin G in Neisseria meningitidis is mainly due to alterations in PBP2 encoded by the penA gene. However, this phenotype was not associated with reduced susceptibility to third-generation cephalosporins (C3Gs). We aimed to study the emergence of meningococci with reduced susceptibility to C3Gs (MIC >0.06 mg/L) in France since 2012. METHODS: Invasive meningococcal isolates were typed by MLST and penA sequencing and their antibiotic susceptibility was tested. RESULTS: Isolates with reduced susceptibility to C3Gs represented 2% of all invasive isolates from 2012-15, but were absent before. They harboured a new penA allele, penA327, that was also detected in isolates from urethritis cases and in gonococci. CONCLUSIONS: Surveillance of these isolates should be enhanced as they may jeopardize the use of C3Gs in the management of invasive meningococcal disease.
Authors: Kevin C Ma; Magnus Unemo; Samo Jeverica; Robert D Kirkcaldy; Hideyuki Takahashi; Makoto Ohnishi; Yonatan H Grad Journal: J Clin Microbiol Date: 2017-09-13 Impact factor: 5.948
Authors: Caelin C Potts; Adam C Retchless; Lucy A McNamara; Daya Marasini; Natashia Reese; Stephanie Swint; Fang Hu; Shalabh Sharma; Amy E Blain; David Lonsway; Maria Karlsson; Susan Hariri; LeAnne M Fox; Xin Wang Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 20.999
Authors: Elizabeth M Batty; Tomas-Paul Cusack; Janjira Thaipadungpanit; Wanitda Watthanaworawit; Verena Carrara; Somsavanh Sihalath; Jill Hopkins; Sona Soeng; Clare Ling; Paul Turner; David A B Dance Journal: Int J Infect Dis Date: 2020-04-08 Impact factor: 3.623
Authors: Mingliang Chen; Odile B Harrison; Holly B Bratcher; Zhiyan Bo; Keith A Jolley; Charlene M C Rodrigues; James E Bray; Qinglan Guo; Xi Zhang; Min Chen; Martin C J Maiden Journal: Emerg Infect Dis Date: 2021-04 Impact factor: 6.883